Dr. Barbara Schug

Barbara Schug, co-founder and long-term Managing Director of SocraMetrics, handed Company Management over to Juliana Brudel and André Warnke in 2022. She shaped and still represents the corporate culture and innovative potential of SocraMetrics - coupled with high sustainability and quality standards. With her many years of expertise in drug development, she continues to play a crucial role as a Scientific Adviser.

As a pharmacist with a PhD in experimental pharmacology and many years of CRO experience, she brought the necessary experience and expertise to provide the company with the standards appropriate to modern drug development. From the beginning, her efforts in SocraMetrics have been focused on implementing high quality data management and statistical analysis with the highest quality standards, following the basic principles of CFR 21 Part 11, GAMP-5 and a CDASH-based data design. Barbara Schug's original "early phase" oriented work focus has naturally added excellent pharmacokinetic analysis as a building block to the company's service units.

Barbara Schug brings with her a great treasure of experience and excellent interdisciplinary knowledge. Her intensive networking in industry, authorities and universities allows her to call in proven experts when her own knowledge reaches its limits. The optimal solution for the customer is always in the foreground for her.